Orthocell partner receives US FDA clearance for marine-derived bone graft

Special Report: Orthocell’s strategic partner Marine Biomedical has received US Food and Drug Administration (FDA) 510 (k) clearance for PearlBone, a next-generation bone…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.ntnews.com.au)